About
A Prolog co-founder and managing director, Greg has been active in venture capital for more than 30 years. He has played a pivotal role in the early-stage funding of companies like Genelabs, Novellus, UroCor and Stereotaxis, all which later went public. Prior to Prolog, Greg was a general partner at the venture capital firm Gateway Associates, where he focused on early-stage investments in medical technology and advanced materials. Greg began his investing career in 1985 as vice president of venture capital at Monsanto. There he oversaw Monsanto’s $80 million portfolio of venture capital investments and was one of the architects of its international network of venture funds, including its pioneering technology fund in the UK. Greg holds a doctorate in physics from the University of Rochester and a bachelor’s degree from MIT.
Position in the VCSift Database
- • 6 investors at Prolog Ventures are tracked.
- • 160 investors hold the Founder & Managing Director role in VCSift. Greg Johnson is one of them.
- • 257 investors are based in St Louis, Missouri, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- St Louis, US
Contact Information
Find more investors like Greg
Search Investors